Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naive Metastatic Clear-Cell Renal Cell Carcinoma

Bedke, Jens; Albiges, Laurence; Capitanio, Umberto; Giles, Rachel H.; Hora, Milan; Lam, Thomas B.; Ljungberg, Borje; Marconi, Lorenzo; Klatte, Tobias; Volpe, Alessandro; Abu-Ghanem, Yasmin; Dabestani, Saeed; Fernandez-Pello, Sergio; Hofmann, Fabian; Kuusk, Teele; Tahbaz, Rana; Powles, Thomas; Bex, Axel

Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naive Metastatic Clear-Cell Renal Cell Carcinoma

Autor(en):

Bedke, Jens; Albiges, Laurence; Capitanio, Umberto; Giles, Rachel H.; Hora, Milan; Lam, Thomas B.; Ljungberg, Borje; Marconi, Lorenzo; Klatte, Tobias; Volpe, Alessandro; Abu-Ghanem, Yasmin; Dabestani, Saeed; Fernandez-Pello, Sergio; Hofmann, Fabian; Kuusk, Teele; Tahbaz, Rana; Powles, Thomas; Bex, Axel

Tübinger Autor(en):

Bedke, Jens

Erschienen in:

European Urology (2021), Bd. 79, H. 3, S. 339-342

Verlagsangabe:

Elsevier

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/j.eururo.2020.12.005

ISSN:

1873-7560